View Main Condition: Leukemia
Tapan Kadia is an Oncologist and a Hematologist Oncology expert in Houston, Texas. Kadia has been practicing medicine for over 22 years and is rated as an Elite expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). He is also highly rated in 41 other conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. He is licensed to treat patients in Texas. Kadia is currently accepting new patients.
Alexandra Schrader practices in Koeln, Germany. Schrader is rated as an Elite expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). She is also highly rated in 3 other conditions, according to our data. Her top areas of expertise are Prolymphocytic Leukemia, Chronic T-Cell Leukemia (CTCL), Adult T-Cell Leukemia, and Leukemia.
Marco Herling practices in Köln, Germany. Herling is rated as an Elite expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). He is also highly rated in 11 other conditions, according to our data. His top areas of expertise are Prolymphocytic Leukemia, Chronic T-Cell Leukemia (CTCL), Adult T-Cell Leukemia, Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Transplant.
Summary: This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on people with relapsed or refractory NK-cell or T-cell lymphoma.
Summary: This phase II trial studies how well letermovir works for the prevention of cytomegalovirus reactivation in patients with hematological malignancies treated with alemtuzumab. Patients receiving treatment with alemtuzumab may experience cytomegalovirus reactivation. Letermovir may block cytomegalovirus replication and prevent infection.